Purchase Order HHSN272201800367P
Award Date 1/31/18
Potential Completion Date 1/30/19
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $14,093.48, is for the provision of Illumina NextSeq XT DNA sequencing kits. The contract has no set-aside designation. Through past prime contract awards, Illumina has provided a range of sequencing instruments, reagents, and services to...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $5,212.06 contract is for the provision of next-generation sequencing kits to support genomic research and diagnostics. Illumina has a history of providing sequencing systems, reagents, and associated services to federal agencies...
- This $222,250.66 firm fixed price delivery order was awarded to Illumina, Inc. by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the provision of NextSeq 500/550 High Output Kit V2.5 and Tagment DNA Enzyme and Buffer Small Kit to support genomic sequencing and analysis. This award does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions that...
- This is a $7,460.28 firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for Illumina's NextSeq 500/550 High Output Kit V2 (150 cycles), with a completion date of July 15, 2017. There is no set-aside designation for this award. Illumina has previously received prime federal contract and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for Illumina HiSeq library preparation and cluster kits. The award has a ceiling value of $3,144 and was made on a non-set-aside basis. Illumina is a manufacturer and provider of genetic and genomic analysis solutions, including a range of DNA sequencing instruments and reagents used across federal...
- This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $12,058.24 contract is for the procurement of Illumina sequencing kits and does not have a set-aside designation. Illumina has been awarded multiple prime federal contracts and grants, primarily focused on providing advanced genomic sequencing...
- This is a $55,683.31 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of Illumina DNA Prep Kits, Nextera Kits, and RNA Prep Kits, which support nucleic acid sequencing needs. Illumina has a history of providing sequencing systems, reagents, and related products and services to various...